biomedicina slovenica

re="Cancer" : 308-407

  1. Kovač V; Zwitter M; Smrdel U; Debeljak A; Cesar R; Kern I
    Low-dose gemcitabine in prolonged infusion and cisplatin for malignant pleural mesothelioma: a phase I and II trials
    2004 ►
  2. Strojan Primož; Jereb Berta; Popović Mara; Šurlan Katarina
    Successful therapy of choroid plexus carcinoma
    2004 ►
  3. Takač I; Arko D; Bali R; Čas-Sikošek N; Gorišek B; Zukanović D
    CA 125 is not a suitable tumor marker for prediction of disease status and lymph node metastasis in patients with endometrial cancer
    2004 ►
  4. Zwitter Matjaž
    Designing clinical trials for elderly patients
    2003 ►
  5. Paridaens R; Therasse P; Dirix L; Beex L; Piccart MJ; Cameron D; Čufer T; Roozendael K; Nooy M; Mattiacci MR
    First results of a randomized phase III trial comparing exemestane versus tamoxifen as first-line hormone therapy (HT) for postmenopausal women with metastatic breast cancer (MBC) - EORTC 10951 in collaboration with the exemestane working group and NCIC clinical trials group
    2004 ►
  6. Matos E; Borstnar S; Vrhovec I; Svetič B; Čufer T
    PAI-1 and PAI-2 as predictive factors in breast cancer
    2004 ►
  7. Drev P; Golouh R; Snoj Nataša; Čufer T
    Correlation between Her-2 status in primary tumour and response to anastrozole in patients with metastatic breast cancer
    2004 ►
  8. Pajk B; Borštnar S; Snoj Nataša; Čufer T
    Disease free survival (DFS) in breast cancer patients older than 70 years compered to younger patients groups
    2004 ►
  9. Paridaens R; Dyczka J; Rutgers EJT; Coleman R; Čufer T; Jassem J; Nortier JRW; Morales L; Mattiacci MR; Therasse P; Gasthuisberg UZ
    Postoperative adjuvant chemotherapy folowed by adjuvant tamoxifen versus nil for patients with operable breast cancer. First results of a randomized phase III trial EORTC 10901
    2004 ►
  10. Snoj Nataša; Pajk B; Borštnar S; Čufer T
    The benefits of adjuvant hormonal therapy in patients with early breast cancer 35 years old or younger
    2004 ►
  11. Piškur P; Sonc M; Čufer T; Borštnar S; Mrhar A
    Pharmacoeconomics aspects of adjuvant early breast cancer treatment in postmenopausal women with anastrozole or tamoxifen: a Slovenian perspective
    2004 ►
  12. Trihia Helen; Golouh Rastko; Lamovec J; Jančar J; Lindtner J; Novak J; Eržen D; Naglas M; Senčar M; Červek J; Cerar O; Štabuc B; Šebek S
    Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors - a surrogate marker?
    2003 ►
  13. Kitanovski L; Derganc M; Jazbec J; Dolničar M; Anžič J; Mali P; Krhin B; Hojker S; Gubina M
    The role of IL-6 in early diagnosis of severe infections in children with febrile neutropenia
    2003 ►
  14. Hajdinjak Tine; Toplak Nataša
    E-cadherin polymorphism - 160 C/A and prostate cancer
    2004 ►
  15. Smits Kim M; Benhamou Simone; Garte Seymour; Weijenberg Matty P; Alamanos Yannis; Ambrosone Christine; Autrup Herman; Autrup Judith L; Baranova Helena; Dolžan Vita
    Association on metabolic gene polymorphisms with tobacco consumption in healthy controls
    2004 ►
  16. Snoj Marko
    Application of surgical gamma probe: the principles and practice
    2003 ►
  17. Lamovec J; Wotherspoon A; Jacquemier J
    Malignant lymphoma and metastatic tumours
    2003 ►
  18. Trihia Helen; Murray Susan; Price Karen; Gelber Richard D; Golouh Rastko; Goldhirsch Aron; Coates Alan S; Collins John; Castiglione-Gertsch Monica; Gusterson Barry A
    Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors - a surrogate marker?
    2003 ►
  19. Atalay G; Biganzoli L; Renard F; Paridaens R; Čufer T; Coleman R; Calvert AH; Gamucci T; Minisini A; Therasse P
    Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials
    2003 ►
  20. Goldhirsch A; Lindtner J; Eržen D; Majdič E; Štabuc B; Plesničar A; Golouh R; Lamovec J; Jančar J; Vrhovec I; Kramberger M
    Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial
    2003 ►
  21. Krzakowski Maciej; Wenczl Miklos; Brodowicz Thomas; Tzekova Valentina; Ramlau Rodryg; Ghilezan Nicolae; Cucevic Branka; Gyurkovits Kalman; Zwitter Matjaž
    Gemcitabine and cisplatin (GC)+/- subsequent maintenance therapy with single-agent gemcitabine in advanced non-small cell lung cancer (NSCLC): preliminary results of a randomized trial of the Central European cooperative oncology group (CECOG)
    2003 ►
  22. Podkrajšek M; Hertl K; Hočevar M; Žgajnar J; Bešić N; Bračko M
    Axillary ultrasound (US) and US-guided fine needle aspiration biopsy in the assessment of lymph-node metastases in breast cancer patients
    2003 ►
  23. Velepič M; Skela-Savič B; Koren P
    An impact of internal quality control in oncology nursing care
    2003 ►
  24. Strojan P; Svetic B; Šmid L; Kos J
    Cysteine proteinase inhibitor cystatin C (CC) in operable squamous cell carcinoma of the head and neck (SCCHN): expression pattern and relation to prognosis
    2003 ►
  25. Oblak I; Strojan P; Zakotnik B; Budihna M; Šmid L
    Hemoglobin as a factor influencing the outcome in inoperable oropharyngeal carcinoma treated by concomitant radiochemotherapy
    2003 ►
  26. Bešić N; Žgajnar J; Bergant D; Hočevar M; Pompe F
    Prognostic factors in follicular and Huerthle cell carcinoma of the thyroid gland - a multivariate survival analysis
    2003 ►
  27. Bergant D; Glavač D; Bešić N; Hočevar M
    Medullary thyroid carcinoma (MTC): genetic screening in Slovenia 1997-2002
    2003 ►
  28. Snoj M; Vidergar-Kralj B
    Added value of blue dye in sentinel node biopsy for breast cancer
    2003 ►
  29. Fras A
    High rate of urological complications in patients with carcinoma of the cervix, figo stages IIB-III, following 'salvage' surgical treatment
    2003 ►
  30. Spataro Vito J; Lamovec J; Jančar J; Nowak J; Eržen D; Naglas M; Senčar M; Červak J; Cerar O; Štabuc B; Šebek S; Čufer T
    Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International breast study group trial 5
    2003 ►
  31. Colleoni M; Litman HJ; Castiglione-Gertsch M; Sauerbrei W; Gelber RD; Bonetti M; Coates AS; Schumacher M; Bastert G; Lindtner J
    Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF
    2002 ►
  32. Spataro Vito J; Litman Heather; Viale Giuseppe; Maffini Fausto; Masullo Michele; Golouh Rastko; Lindtner Jurij
    Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from international breast cancer study group trial V
    2003 ►
  33. Hočevar M; Bračko M; Pogačnik A; Vidergar-Kralj B; Bešić N; Žgajnar J
    Role of imprint cytology in the intraoperative evaluation of sentinel lymph nodes for malignant melanoma
    2003 ►
  34. Lokajner G; Laznik K; Plenovski-Plevčak D
    Collaboration between oncology unit and pharmacy department - benefits for nursing practice
    2001 ►
  35. Žgajnar Janez
    DCIS general strategy - multidisciplinary approach
    2003 ►
  36. Štabuc Borut
    Uracil/tegafur plus oral leucovorin does not affect survival rates but may be better tolerated than standard fluorouracil and leucovorin for previously untreated metastatic colorectal cancer [comment]
    2003 ►
  37. Triller Nadja; Kecelj Peter; Kern Izidor
    Endobronchial ultrasound guided transbronchial needle aspiration in the diagnosis of tracheobronchial and mediastinal lesions and in peripheral pulmonary tumours
    2003 ►
  38. Triller Nadja; Debeljak Andrej; Kecelj Peter; Eržen Damijan; Kern Izidor; Debevec Lučka
    Diagnostic procedures in peripheral pulmonary tumours in 1996 and 2001 - a retrospective comparative study
    2003 ►
  39. Devilee P; Logar N; Golouh R
    Loss of heterozygosity at 7q31 in breast cancer: results from an International collaborative study group
    1997 ►
  40. Glavač Damjan; Volavšek Metka; Potočnik Uroš; Ravnik-Glavač Metka; Gale Nina
    Low microsatellite instability and high loss of heterozygosity rates indicate dominant role of the suppressor pathway in squamous cell carcinoma of head and neck and loss of heterozygosity of 11q14.3 correlates with tumor grade
    2003 ►
  41. Paridaens R; Dirix L; Beex L; Nooij MN; Čufer T; Lohrisch C; Biganzoli L; van Hoorebeeck I; Duchateau L; Lobelle JP; Piccart M
    Promising results with exemestane in the first-line treatment of metastatic breast cancer: a randomized phase II EORTC trial with a tamoxifen control
    2000 ►
  42. Bonnefoi H; Biganzoli L; Mauriac L; Čufer T; Schaefer P; Atalay G; Piccart M
    An EORTC phase I study of capecitabine (xeloda) in combination with fixed doses of cyclophosphamide and epirubicin (cex) as primary treatment for large operable or locally advanced/inflammatory breast cancer
    2003 ►
  43. Zwitter Matjaž
    Comments on treatment strategy for locally advanced non-small cell lung cancer
    2002 ►
  44. Akehurst RL; Beinert T; Crawford J; Crino L; Debus J; Eckersberger F; Fischer J; Georgoulias V; Gridelli C; Zwitter M
    Consensus on medical treatment of non-small cell lung cancer
    2002 ►
  45. Čufer Tanja
    Palliative and supportive care
    2003 ►
  46. Žgajnar Janez
    Sentinel lymphnode biopsy - from clinical trial to practice
    2003 ►
  47. Primic-Žakelj Maja
    Epidemiology of breast cancer
    2003 ►
  48. Kotnik V; Škoberne M; Kotnik A; Kirschfink M
    Antibody dependent complement activation induces apoptosis of human embrional kidney epithelial cells
    2002 ►
  49. Levičar Nataša; Dewey Ricardo A; Daley Em,ma; Bates Timothy E; Davies Derek; Kos Janko; Pilkington Geoffrey J; Lah Tamara T
    Selective suppression of cathepsin L by antisense cDNA impairs human brain tumor cell invasion in vitro and promotes apoptosis
    2003 ►
  50. Serša Gregor; Čemažar Maja; Rudolf Zvonimir
    Electrochemotherapy: advantages and drawbacks in treatment of cancer patients
    2003 ►
  51. Mekid H; Tounekti O; Spatz A; Čemažar M; El-Kebir FZ; Mir LM
    In vivo evolution of tumour cells after the generation of double-strand DNA breaks
    2003 ►
  52. Potrč S; Kavalar R; Hajdinjak T; Horvat M; Vidovič D
    What did we learn in surgical treatment of gastric adenocarcinoma ecomparison of two periods
    2003 ►
  53. Horvat M; Potrč S
    Gastric cancer surgery for the elderly: where are the borders?
    2003 ►
  54. Cauley Jane A; Norton Larry; Lippman Marc E; Eckert Stephen; Krueger Kathryn A; Purdie David W; Farrerons Jordi; Karasik Avraham; Mellstrom Dan; Kocijančič Andreja
    Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial
    2001 ►
  55. Kecelj P; Debeljak A; Triller N; Osolnik K; Eržen D; Kern I
    Transbronchial aspiration of the peripheral lung infiltrate
    2002 ►
  56. Potočnik Uroš; Glavač Damjan; Ravnik-Glavač Metka
    Identification of novel genes with somatic frameshift mutations within coding mononucleotide repeats in colorectal tumors with high microsatellite instability
    2003 ►
  57. Serša G; Kržič M; Šentjurc M; Ivanuša T; Beravs K; Kotnik V; Coer A; Swartz HM; Čemažar M
    Reduced blood flow and oxygenation in SA-I tumours after electrochemotherapy with cisplatin
    2002 ►
  58. Biganzoli Laura; Čufer Tanja; Bruning Peter; Coleman Robert E; Duchateau Luc; Rapoport Bernardo; Nooij Marianne; Delhaye Francois; Miles D; Sulkes Aaron
    Doxorubicin-paclitaxel: a safe regimen in terms of cardiac toxicity in metastatic breast carcinoma patients. Results from a European organization for research and treatment of cancer multicenter trial
    2003 ►
  59. Čemažar M; Auersperg M; Ščančar J; Srebotnik-Kirbiš I; Pogačnik A; Serša G
    Interactions between vinblastine and cisplatin in EAT tumours in mice: schedule dependency
    2002 ►
  60. Zukanović D; Bali R; Čas-Sikošek N; Gorišek B; Takač I
    Human papillomavirus 16/18 infection and sexual behaviour in patient with cervical intraepithelial neoplasia
    2003 ►
  61. Snoj Marko
    Application of surgical gamma probe: the principles and practice
    2001 ►
  62. Vineis Paolo; Veglia Fabrizio; Benhamou Simone; Butkiewicz Dorota; Cascorbi Ingolf; Clapper Margie L.; Dolžan Vita; Haugen Aage; Hirvonen Ari; Ingelman-Sundberg Magnus
    CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls
    2003 ►
  63. Takač I; Bali R; Čas-Sikošek N; Gorišek B; Zukanović D
    Correlation of serum CA 125 levels and lymph node metastasis in endometrial carcinoma
    2003 ►
  64. Možina Andrej; Rakar Stelio
    Training and quality assurance in colposcopy
    2003 ►
  65. Uršič-Vrščaj Marjetka; Kovačič Jule; Vrtačnik-Bokal Eda; Možina Andrej; Rakar Stelio
    Določanje onkogenih humanih virusov papiloma v Sloveniji
    2003 ►
  66. Syrjaenen Kari
    Methods and role of HPV detection techniques as auxiliary screening tools
    2003 ►
  67. Schenck Ulrich; Schenck Ulrike
    New methods of teaching and their application to cytology multilingual image gallery and web based training in cytology
    2003 ►
  68. Trutin-Ostović Karmen
    Training and education of cytotechnologists and clinical cytologists in gynecologic cytology in Croatia
    2003 ►
  69. Branca Margherita
    Italian experience in training and education of cytotechnologists and cytopathologists in gynecological cytology and cervical cancer screening: external quality control in laboratories of gynecological cytology in Italy
    2003 ►
  70. Možina A; Rakar S
    Incidence of cervical carcinoma in Slovenia: results of our analysis
    2003 ►
  71. Kovačič Julij; Hvalec Štefka; Levičnik Ana; Debevec Marija; Eržen Mojca
    Petdeset let ginekološke citologije na Ginekološki kliniki v Ljubljani
    [Fifty years of gynecologic cytology at the Department of obstetrics and gynecology in Ljubljana]
    2003 ►
  72. Primic-Žakelj Maja
    Epidemiology of cervical cancer in Slovenia and "ZORA" programme
    2003 ►
  73. Eržen Mojca; Branca Margherita; Syrjaenen Kari; Coleman Dulcie V
    The PAP test procedure, quality assurance and continuous quality improvement in laboratories participating in cervical cancer screening. Presentation of the items produced by Leonardo da Vinci 2000 project of European union
    2003 ►
  74. Primic-Žakelj Maja; Pompe-Kirn Vera; Škrlec Fani
    Evaluation of cervical cancer screening in Slovenia
    2002 ►
  75. Ećimović P; Pompe-Kirn V
    Second primary cancers in laryngeal cancer patients in Slovenia, 1961-1996
    2002 ►
  76. Arlt Volker M; Ferluga Dušan; Stiborova Marie; Pfohl-Leszkowicz Annie; Vukelić Mato; Ceović Stjepan; Schmeiser Heinz H; Cosyns Jean-Pierre
    Is aristolochic acid a risk factor for Balkan endemic nephropathy-associated urothelial cancer?
    2002 ►
  77. Zajc Irena; Sever Nataša; Bervar Aleš; Lah Tamara T
    Expression of cysteine peptidase cathepsin L and its inhibitors stefins A and B in relation to tumorigenicity of breast cancer cell lines
    2002 ►
  78. Takač I; Bali R; Čas-Sikošek N; Gorišek B; Zukanović D; Žegura B
    Comprehensive inquiry and computer program for patients with ovarian cancer
    2002 ►
  79. Snoj Marko
    Application of surgical gamma probe: the principles and practice
    2002 ►
  80. Takač Iztok; Bali Robert; Čas-Sikošek Nina; Gorišek Borut; Zukanovič Dunja; Žegura Branka
    Comprehensive inquiry and computer program for patients with ovarian cancer
    2002 ►
  81. Fras AP; Šušteršič M
    A novel technical approach to intraperitoneal chemotherapy (IPC)
    2001 ►
  82. Debeljak A
    Endobronchial laser resection
    2002 ►
  83. Herzog Branka; Hendrick JC; Franchimont P
    Heterogeneity of carcinoemenbryonic antigen (CEA) in human serum
    1976 ►
  84. Debevec L; Debeljak A; Eržen J; Kovač V; Kern I
    Management and survival of lung cancer patients diagnosed within one year in a single institution
    2002 ►
  85. Debeljak A
    Endobronchial laser resection
    2002 ►
  86. Debeljak A; Kecelj P; Triller N; Debevec M; Kovač V; Osolnik K; Kern I; Rott T; Eržen D; Polak D
    Treatment of small cell lung cancer with ifosfamide and etoposide
    2002 ►
  87. Triller N; Kern I
    Endobronchial ultrasoun-guided transbronchial needle aspiration-staging of lung cancer
    2002 ►
  88. Debeljak A; Triller N; Kecelj P; Kern I
    Auto fluorescence bronchoscopy in the diagnosis of preneoplastic changes and bronchial carcinoma
    2002 ►
  89. Čufer T
    Symptomatic and supportive care in metastatic disease
    2002 ►
  90. Lambert Rene; Guilloux Agathe; Oshima Akira; Pompe-Kirn Vera; Bray Freddie; Parkin Max; Ajiki Wakiko; Tsukuma Hideaki
    Incidence and mortality from stomach cancer in Japan, Slovenia and the USA
    2002 ►
  91. Awada A; Biganzoli L; Čufer T; Beex L; Lohrisch C; Batter V; Hamilton A; Nooij M; Piccart M
    An EORTC-IDBBC phase I study of gemcitabine and continuous infusion 5-fluorouracil in patients with metastatic breast cancer resistant to anthracyclines or pre-treated with both anthracyclines and taxanes
    2002 ►
  92. Borštnar S; Vrhovec I; Svetič B; Čufer T
    Prognostic value of the urokinase-type plasminogen activator, and its inhibitors and receptor in breast cancer patients
    2002 ►
  93. Brodowicz T; Beslija S; Červek J; Mršič-Krmpotič Z; Tchernozemsky I; Wiltschke C; Ghilezan N; Grgič M; Jassem J; Zielinski C
    Gemcitabine, epirubicin and paclitaxel (GET) vs. 5-fluoro-uracil, epirubicin and cyclophosphamide (FEC) as first-line treatment in metastatic breast cancer: interim toxicity analysis of a randomised, multicenter phase iii trial of the Central European cooperative oncology group (CECOG)
    2001 ►
  94. Biganzoli L; Bonnefoi H; Mauriac L; Čufer T; Kabanga-Ngalula E; Hebert D; Piccart M
    Cyclophosphamide (C) - Epirubicine (E) - Capecitabine (X) combination, CEX: a safe and active regimen in the treatment of locally advanced/inflammatory (LA/I) or large operable (LO) breast cancer (BC). An EORTC-IDBBC study
    2001 ►
  95. Žgajnar J; Hočevar M; Bešić N; Vrščaj M; Pajk B; Čufer T; Jakopin C; Krajc M
    Genetic counceling for hereditary breast and ovarian cancer. Our experience at the Institute of oncology in Ljubljana, Slovenija
    2002 ►
  96. Jagodic M; Vrhovec I; Borštnar S; Matos E; Čufer T
    Prognostic value of different proteolitic factors in primary breast cancer
    2002 ►
  97. Matos E; Vrhovec I; Borštnar S; Jagodic M; Čufer T
    Predictive value of PAI-1 and PAI-2 in breast cancer
    2002 ►
  98. Pajk B; Borštnar S; Vrhovec I; Čufer T
    PAI-1 is independant prognostic factor in the elderly breast cancer patients
    2002 ►
  99. International breast cancer study group J; Eržen D; Majdič E; Štabuc B; Plesničar A; Golouh R; Lamovec J; Jančar J; Vrhovec I; Kramberger M
    Endocrine responsiveness and tailoring adjuvant therapy for postmenopausal lymph node-negative breast cancer: a randomized trial
    2002 ►
  100. Levičar Nataša; Kos Janko; Blejec Andrej; Golouh Rastko; Vrhovec Ivan; Frkovič-Grazio Snježana; Lah Tamara T
    Comparison of potential biological markers cathepsin B, cathepsin L, stefin A, and stefin B with urokinase and plasminogen activator inhibitor-1 and clinicopathological data of breast carcinoma patients
    2002 ►

   1 8 108 208 308 408 508 608 708  


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics